423 related articles for article (PubMed ID: 17057739)
1. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
Rabins PV; Lyketsos CG
Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
[No Abstract] [Full Text] [Related]
2. FDA approves groundbreaking Alzheimer's drug.
Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
[No Abstract] [Full Text] [Related]
3. Drugs for Alzheimer's disease.
Cranwell-Bruce LA
Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985
[No Abstract] [Full Text] [Related]
4. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
5. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
Wellhöfer B
Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237
[No Abstract] [Full Text] [Related]
6. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
[No Abstract] [Full Text] [Related]
7. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Schölzel-Dorenbos CJ;
Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
[TBL] [Abstract][Full Text] [Related]
9. Variability in the prescription of cholinesterase inhibitors and memantine.
Villar-Fernández I; Bjerrum L; Feja C; Rabanaque MJ
Dement Geriatr Cogn Disord; 2009; 28(4):373-9. PubMed ID: 19887800
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: will advances made in the past turn the tide?
Semla TP
Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
[No Abstract] [Full Text] [Related]
11. A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.
Jones RW
Int J Geriatr Psychiatry; 2010 Jun; 25(6):547-53. PubMed ID: 20049770
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic therapeutic aspects in Alzheimer's disease.
Gauthier S
Handb Clin Neurol; 2008; 89():269-71. PubMed ID: 18631751
[No Abstract] [Full Text] [Related]
14. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy for Alzheimer's disease].
Shoji M
Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
[TBL] [Abstract][Full Text] [Related]
16. Therapies for Alzheimer's disease.
Melnikova I
Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055
[No Abstract] [Full Text] [Related]
17. [Drug therapy of Alzheimer dementia].
Skausig OB; Laugesem LP; Jensen T
Ugeskr Laeger; 2003 Jul; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
[No Abstract] [Full Text] [Related]
18. New developments in the treatment of Alzheimer's disease.
J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
[No Abstract] [Full Text] [Related]
19. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of action of Alzheimer medications].
Alhainen K
Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
